全文获取类型
收费全文 | 1666篇 |
免费 | 126篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 62篇 |
妇产科学 | 24篇 |
基础医学 | 235篇 |
口腔科学 | 38篇 |
临床医学 | 206篇 |
内科学 | 305篇 |
皮肤病学 | 85篇 |
神经病学 | 146篇 |
特种医学 | 93篇 |
外科学 | 164篇 |
综合类 | 21篇 |
预防医学 | 169篇 |
眼科学 | 24篇 |
药学 | 73篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 9篇 |
2022年 | 25篇 |
2021年 | 31篇 |
2020年 | 25篇 |
2019年 | 16篇 |
2018年 | 52篇 |
2017年 | 29篇 |
2016年 | 41篇 |
2015年 | 44篇 |
2014年 | 62篇 |
2013年 | 71篇 |
2012年 | 111篇 |
2011年 | 129篇 |
2010年 | 67篇 |
2009年 | 63篇 |
2008年 | 87篇 |
2007年 | 91篇 |
2006年 | 101篇 |
2005年 | 121篇 |
2004年 | 70篇 |
2003年 | 79篇 |
2002年 | 73篇 |
2001年 | 25篇 |
2000年 | 31篇 |
1999年 | 32篇 |
1998年 | 19篇 |
1997年 | 16篇 |
1996年 | 17篇 |
1995年 | 8篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 11篇 |
1991年 | 11篇 |
1990年 | 12篇 |
1989年 | 10篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 15篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1979年 | 9篇 |
1978年 | 6篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1970年 | 8篇 |
1969年 | 9篇 |
1968年 | 8篇 |
1967年 | 7篇 |
排序方式: 共有1800条查询结果,搜索用时 15 毫秒
21.
Lisa Marlene Krassuski Sibylle Kautz-Freimuth Vera Vennedey Kerstin Rhiem Rita K. Schmutzler Stephanie Stock 《Geburtshilfe und Frauenheilkunde》2021,81(6):679
Introduction Women with a pathogenic BRCA1/2 mutation have a markedly increased lifetime risk of developing breast and/or ovarian cancer. The current preventive treatment alternatives that are offered are an intensified breast cancer screening programme and risk-reducing operations. Before deciding on one option, medical and personal factors such as life situation and individual preferences must be weighed carefully. Decision aids are used internationally to support BRCA1/2 mutation carriers during their decision-making process. In this study these are analysed structurally for the first time and their applicability to the German context is examined. Material and Methods A systematic literature search in five electronic databases and a manual search were performed. The identified decision aids were evaluated with regard to formal criteria, medical content and quality. The qualitative assessment used the criteria of the International Patient Decision Aid Standards Collaboration (IPDASi v4.0), which examined various dimensions (e.g., information, probabilities, values). Results Twenty decision aids, which were published between 2003 and 2019 in Australia (n = 4), the United Kingdom (n = 3), Canada (n = 2), the Netherlands (n = 2) and the USA (n = 9), were included. Nine focus on BRCA1/2 mutation carriers and eleven include other risk groups. Eighteen include risk-reducing operations as decision options, 14 list screening methods for breast and/or ovarian cancer, and 13 describe the possibility of pharmacological prevention by means of selective oestrogen receptor modulators or aromatase inhibitors. Nine of the 20 decision aids meet fundamental quality criteria (IPDASi v4.0 qualification criteria). Conclusion International decision aids can serve formally as a basis for a German decision aid for BRCA1/2 mutation carriers. Some of them differ markedly in content from the recommendations of German guidelines. Only a few achieve a high quality. Key words: BRCA1, BRCA2, decision aid, familial breast cancer, familial ovarian cancer 相似文献
22.
Dosage guidelines and side effects of three currently available protease inhibitors (saquinavir, ritonavir, indinavir) reveal very different patterns. Dosage regimens are as follows: saquinavir, 3 capsules every 8 hours with food; ritonavir, 6 capsules every 12 hours with food; and indinavir, 2 capsules every 8 hours on an empty stomach. Ritonavir has the severest side effects, including nausea, diarrhea, and initially, tingling feeling of the mouth, arms, or legs. The drugs work best when taken with well-studied medicines such as AZT, d4T, and ddI. 相似文献
23.
Gray DR Namikas EA Sax MJ Brinkman J Cheung A Gordon M Parker AG Welch PH 《Contemporary pharmacy practice》1979,2(3):108-116
The effect of clinical pharmacy services on the quality and economy of health care provided to psychiatric patients at a Veterans Administration outpatient clinic was evaluated. Twenty-one patients were selected from the Day Treatment Center, of these, 19 patients completed the study. In providing health care to these psychiatric patients, the clinical pharmacist used a systemized approach including data gathering, evaluation, plan of action, and follow-up. In addition, medication groups and weekly staff meetings were incorporated into the patient treatment plan. Following a 3-month study period, the impact of clinical pharmacy services was evaluated. The provision of allied health care to psychiatric patients by clinical pharmacists resulted in a decreased incidence and severity of adverse drug effects, fewer drug use problems, a reduction in the total number of drugs prescribed, improved patient drug knowledge, and reduced expenditures for health care without compromising the patient's mental functioning. 相似文献
24.
25.
Kathrin Mühlemann Christine Franzini Christoph Aebi Christoph Berger David Nadal Jody St?helin Hanspeter Gnehm Klara Posfay-Barbe Alain Gervaix Hugo Sax Ulrich Heininger Jan Bonhoeffer Gerhard Eich Christian Kind Christiane Petignat Pietro Scalfaro 《Infection control and hospital epidemiology》2004,25(9):765-771
OBJECTIVE: To acquire data on pediatric nosocomial infections (NIs), which are associated with substantial morbidity and mortality and for which data are scarce. DESIGN: Prevalence survey and evaluation of a new comorbidity index. SETTING: Seven Swiss pediatric hospitals. PATIENTS: Those hospitalized for at least 24 hours in a medical, surgical, intensive care, or intermediate care ward. RESULTS: Thirty-five NIs were observed among 520 patients (6.7%; range per hospital, 1.4% to 11.8%). Bacteremia was most frequent (2.5 per 100 patients), followed by urinary tract infection (1.3 per 100 patients) and surgical-site infection (1.1 per 100 patients; 3.2 per 100 patients undergoing surgery). The median duration until the onset of infection was 19 days. Independent risk factors for NI were age between 1 and 12 months, a comorbidity score of 2 or greater, and a urinary catheter. Among surgical patients, an American Society of Anesthesiologists (ASA) score of 2 or greater was associated with any type of NI (P = .03). Enterobacteriaceae were the most frequent cause of NI, followed by coagulase-negative staphylococci; viruses were rarely the cause. CONCLUSIONS: This national prevalence survey yielded valuable information about the rate and risk factors of pediatric NI. A new comorbidity score showed promising performance. ASA score may be a predictor of NI. The season in which a prevalence survey is conducted must be considered, as this determines whether seasonal viral infections are observed. Periodic prevalence surveys are a simple and cost-effective method for assessing NI and comparing rates among pediatric hospitals. 相似文献
26.
Gunter von Minckwitz Sebastian Harder Sascha Hövelmann Elke Jäger Salah-Eddin Al-Batran Sibylle Loibl Akin Atmaca Christian Cimpoiasu Antje Neumann Aklil Abera Alexander Knuth Manfred Kaufmann Dirk Jäger Alexander B Maurer Winfried S Wels 《Breast cancer research : BCR》2005,8(1):1-2
Overcoming dendritic cell (DC) dysfunction is a prerequisite for successful active immunotherapy against breast cancer. CD40 ligand (CD40L), a key molecule in the interface between T-lymphocytes and DCs, seems to be instrumental in achieving that goal. Commenting on our data that CD40L protects circulating DCs from apoptosis induced by breast tumor products, Lenahan and Avigan highlighted the potential of CD40L for immunotherapy. We expand on that argument by pointing to additional findings that CD40L not only rescues genuine DCs but also functionally improves populations of immature antigen-presenting cells that fill the DC compartment in patients with breast cancer. 相似文献
27.
28.
29.
30.